From microbial gene essentiality to novel antimicrobial drug targets

BMC Genomics

Volumn 15, Issue 1, 2014, Pages

  Mobegi, Fredrick M ^a   van Hijum, Sacha A F T ^a,b   Burghout, Peter ^a   Bootsma, Hester J ^a   de Vries, Stefan P W ^a,c   van der Gaast de Jongh, Christa E ^a   Simonetti, Elles ^a   Langereis, Jeroen D ^a   Hermans, Peter W M ^a,d   de Jonge, Marien I ^a   Zomer, Aldert ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NIZO FOOD RESEARCH   (Netherlands)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d CRUCELL HOLLAND BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYLURIC ACID; 5' DEOXYADENOSINE; 5,5' DITHIOBIS(2 NITROBENZOIC ACID); 6 FLUOROMEVALONATE DIPHOSPHATE; ANTIINFECTIVE AGENT; CYTOPLASM PROTEIN; UNCLASSIFIED DRUG; TRANSPOSON;

ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL METABOLISM; CELLULAR DISTRIBUTION; DRUG TARGETING; GENE CLUSTER; GENOMICS; HAEMOPHILUS INFLUENZAE; HIGH THROUGHPUT SEQUENCING; INTESTINE FLORA; MORAXELLA CATARRHALIS; MUTAGENESIS; NONHUMAN; STREPTOCOCCUS PNEUMONIAE; TRANSPOSON; BACTERIUM; CELL FRACTIONATION; CELL LINE; DRUG EFFECTS; ESSENTIAL GENE; GASTROINTESTINAL TRACT; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROFLORA; MOLECULAR GENETICS; MULTIGENE FAMILY; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; REPRODUCIBILITY;

ANTI-INFECTIVE AGENTS; BACTERIA; CELL LINE; CONSERVED SEQUENCE; DNA TRANSPOSABLE ELEMENTS; GASTROINTESTINAL TRACT; GENES, ESSENTIAL; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MICROBIAL SENSITIVITY TESTS; MICROBIOTA; MOLECULAR SEQUENCE ANNOTATION; MULTIGENE FAMILY; OPEN READING FRAMES; REPRODUCIBILITY OF RESULTS; SUBCELLULAR FRACTIONS;

EID: 84920848635     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-15-958     Document Type: Article

References (63)

1. Hoban DJ, Doern GV, Fluit AC, Roussel-Delvallez M, Jones RN: Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001, 32(Suppl 2):S81-S93.
2. Lijek RS, Weiser JN: Co-infection subverts mucosal immunity in the upper respiratory tract. Curr Opin Immunol 2012, 24:417-423.
3. Duffield M, Cooper I, McAlister E, Bayliss M, Ford D, Oyston P: Predicting conserved essential genes in bacteria: in silico identification of putative drug targets. Mol Biosyst 2010, 6:2482-2489.
4. Sakharkar KR, Sakharkar MK, Chow VT: A novel genomics approach for the identification of drug targets in pathogens, with special reference to Pseudomonas aeruginosa. In Silico Biol 2004, 4:355-360.
5. Lewis K: Multidrug resistance: Versatile drug sensors of bacterial cells. Curr Biol 1999, 9:R403-R407.
6. Clayton RA, White O, Ketchum KA, Venter JC: The first genome from the third domain of life. Nature 1997, 387:459-462.
7. Qin J, Li R, Raes J, ArumugamM, Burgdorf KS,Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J,Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto JM, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P: A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65.
8. Buffie CG, Pamer EG: Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol 2013, 13:790-801.
9. Ahram M, Springer DL: Large-scale proteomic analysis of membrane proteins. Expert Review of Proteomics 2004, 1:293-302.
10. Yu NY, Laird MR, Spencer C, Brinkman FS: PSORTdb-an expanded, autoupdated, user-friendly protein subcellular localization database for Bacteria and Archaea. Nucleic Acids Res 2011, 39:D241-D244.
11. Molzen TE, Burghout P, Bootsma HJ, Brandt CT, van der Gaast-de Jongh CE, Eleveld MJ, Verbeek MM, Frimodt-Moller N, Ostergaard C, Hermans PW: Genome-wide identification of Streptococcus pneumoniae genes essential for bacterial replication during experimental meningitis. Infect Immun 2011, 79:288-297.
12. Sassetti CM, Boyd DH, Rubin EJ: Comprehensive identification of conditionally essential genes in mycobacteria. Proc Natl Acad Sci U S A 2001, 98:12712-12717.
13. van Opijnen T, Camilli A: Transposon insertion sequencing: a new tool for systems-level analysis of microorganisms. Nat Rev Microbiol 2013, 11:435-442.
14. Barquist L, Boinett CJ, Cain AK: Approaches to querying bacterial genomes with transposon-insertion sequencing. RNA Biol 2013, 10:1161-1169.
15. Chung BK-S, Dick T, Lee D-Y: In silico analyses for the discovery of tuberculosis drug targets. J Antimicrob Chemother 2013, 68:2701-2709.
16. Aziz RK, Bartels D, Best AA, DeJongh M, Disz T, Edwards RA, Formsma K, Gerdes S, Glass EM, Kubal M, Meyer F, Olsen GJ, Olson R, Osterman AL, Overbeek RA, McNeil LK, Paarmann D, Paczian T, Parrello B, Pusch GD, Reich C, Stevens R, Vassieva O, Vonstein V, Wilke A, Zagnitko O: The RAST Server: rapid annotations using subsystems technology. BMC Genomics 2008, 9:75.
17. Li L, Stoeckert CJ Jr, Roos DS: OrthoMCL: identification of ortholog groups for eukaryotic genomes. Genome Res 2003, 13:2178-2189.
18. de Vries SP, Burghout P, Langereis JD, Zomer A, Hermans PW, Bootsma HJ: Genetic requirements for Moraxella catarrhalis growth under ironlimiting conditions. Mol Microbiol 2013, 87:14-29.
19. de Vries SP, Eleveld MJ, Hermans PW, Bootsma HJ: Characterization of the molecular interplay between Moraxella catarrhalis and human respiratory tract epithelial cells. PLoS One 2013, 8:e72193.
20. Burghout P, Cron LE, Gradstedt H, Quintero B, Simonetti E, Bijlsma JJE, Bootsma HJ, Hermans PWM: Carbonic Anhydrase Is Essential for Streptococcus pneumoniae Growth in Environmental Ambient Air. J Bacteriol 2010, 192:4054-4062.
21. Langereis JD, Zomer A, Stunnenberg HG, Burghout P, Hermans PWM: Nontypeable Haemophilus influenzae Carbonic Anhydrase Is Important for Environmental and Intracellular Survival. J Bacteriol 2013, 195:2737-2746.
22. Burghout P, Zomer A, van der Gaast-de Jongh CE, Janssen-Megens EM, Françoijs K-J, Stunnenberg HG, Hermans PWM: Streptococcus pneumoniae Folate Biosynthesis Responds to Environmental CO2 Levels. J Bacteriol 2013, 195:1573-1582.
23. van Opijnen T, Bodi KL, Camilli A: Tn-seq: high-throughput parallel sequencing for fitness and genetic interaction studies in microorganisms. Nat Methods 2009, 6:767-772.
24. Zomer A, Burghout P, Bootsma HJ, Hermans PW, van Hijum SA: ESSENTIALS: software for rapid analysis of high throughput transposon insertion sequencing data. PLoS One 2012, 7:e43012.
25. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M: KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res 2012, 40:D109-D114.
26. Overbeek R, Begley T, Butler RM, Choudhuri JV, Chuang HY, Cohoon M, de Crecy-Lagard V, Diaz N, Disz T, Edwards R, Fonstein M, Frank ED, Gerdes S, Glass EM, Goesmann A, Hanson A, Iwata-Reuyl D, Jensen R, Jamshidi N, Krause L, Kubal M, Larsen N, Linke B, McHardy AC, Meyer F, Neuweger H, Olsen G, Olson R, Osterman A, Portnoy V: The subsystems approach to genome annotation and its use in the project to annotate 1000 genomes. Nucleic Acids Res 2005, 33:5691-5702.
27. Storey JD, Tibshirani R: Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 2003, 100:9440-9445.
28. Yu CS, Chen YC, Lu CH, Hwang JK: Prediction of protein subcellular localization. Proteins 2006, 64:643-651.
29. Zhou M, Boekhorst J, Francke C, Siezen RJ: LocateP: genome-scale subcellular-location predictor for bacterial proteins. BMC Bioinformatics 2008, 9:173.
30. Shen HB, Chou KC: Gneg-mPLoc: a top-down strategy to enhance the quality of predicting subcellular localization of Gram-negative bacterial proteins. J Theor Biol 2010, 264:326-333.
31. Berven FS, Flikka K, Jensen HB, Eidhammer I: BOMP: a program to predict integral beta-barrel outer membrane proteins encoded within genomes of Gram-negative bacteria. Nucleic Acids Res 2004, 32:W394-W399.
32. Bauer AW, Perry DM, Kirby WM: Single-disk antibiotic-sensitivity testing of staphylococci: An analysis of technique and results. AMA Archives of Internal Medicine 1959, 104:208-216.
33. Wiegand I, Hilpert K, Hancock RE: Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc 2008, 3:163-175.
34. Grubbs FE: Procedures for Detecting Outlying Observations in Samples. Technometrics 1969, 11:1-21.
35. Gawronski JD, Wong SM, Giannoukos G, Ward DV, Akerley BJ: Tracking insertion mutants within libraries by deep sequencing and a genomewide screen for Haemophilus genes required in the lung. Proc Natl Acad Sci U S A 2009, 106:16422-16427.
36. Christen B, Abeliuk E, Collier JM, Kalogeraki VS, Passarelli B, Coller JA, FeroMJ, McAdams HH, Shapiro L: The essential genome of a bacterium. Mol Syst Biol 2011, 7:528.
37. Akerley BJ, Rubin EJ, Novick VL, Amaya K, Judson N, Mekalanos JJ: A genome-scale analysis for identification of genes required for growth or survival of Haemophilus influenzae. Proc Natl Acad Sci U S A 2002, 99:966-971.
38. Ochsner UA, Sun X, Jarvis T, Critchley I, Janjic N: Aminoacyl-tRNA synthetases: essential and still promising targets for new anti-infective agents. Expert Opin Investig Drugs 2007, 16:573-593.
39. Campbell JW, Cronan JE Jr: Bacterial fatty acid biosynthesis: targets for antibacterial drug discovery. Annu Rev Microbiol 2001, 55:305-332.
40. Payne DJ, Warren PV, Holmes DJ, Ji Y, Lonsdale JT: Bacterial fatty-acid biosynthesis: a genomics-driven target for antibacterial drug discovery. Drug Discov Today 2001, 6:537-544.
41. Manallack DT, Crosby IT, Khakham Y, Capuano B: Platensimycin: a promising antimicrobial targeting fatty acid synthesis. Curr Med Chem 2008, 15:705-710.
42. Du Q, Wang H, Xie J: Thiamin (vitamin B1) biosynthesis and regulation: a rich source of antimicrobial drug targets? Int J Biol Sci 2011, 7:41-52.
43. Debnath J, Siricilla S, Wan B, Crick DC, Lenaerts AJ, Franzblau SG, Kurosu M: Discovery of selective menaquinone biosynthesis inhibitors against Mycobacterium tuberculosis. J Med Chem 2012, 55:3739-3755.
44. Kronenberger T, Schettert I, Wrenger C: Targeting the vitamin biosynthesis pathways for the treatment of malaria. Future Med Chem 2013, 5:769-779.
45. Bermingham A, Derrick JP: The folic acid biosynthesis pathway in bacteria: evaluation of potential for antibacterial drug discovery. Bioessays 2002, 24:637-648.
46. Dhar MK, Koul A, Kaul S: Farnesyl pyrophosphate synthase: a key enzyme in isoprenoid biosynthetic pathway and potential molecular target for drug development. N Biotechnol 2013, 30:114-123.
47. Lange BM, Rujan T, Martin W, Croteau R: Isoprenoid biosynthesis: the evolution of two ancient and distinct pathways across genomes. Proc Natl Acad Sci U S A 2000, 97:13172-13177.
48. Odom AR: Five questions about non-mevalonate isoprenoid biosynthesis. PLoS Pathog 2011, 7:e1002323.
49. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res 2011, 39:D1035-D1041.
50. Kimmig J: Gerhard Domagk, 1895-1964. Contribution to the chemotherapy of bacterial infections. Internist (Berl) 1969, 10:116-120.
51. Pollak N, Dolle C, Ziegler M: The power to reduce: pyridine nucleotides-small molecules with a multitude of functions. Biochem J 2007, 402:205-218.
52. Sauve AA: NAD + and Vitamin B3: From Metabolism to Therapies. J Pharmacol Exp Ther 2008, 324:883-893.
53. Khedkar SA, Malde AK, Coutinho EC: Comparative protein modeling of methionine S-adenosyltransferase (MAT) enzyme from Mycobacterium tuberculosis: a potential target for antituberculosis drug discovery. J Mol Graph Model 2005, 23:355-366.
54. Perez-Leal O, Moncada C, Clarkson AB, Merali S: Pneumocystis S-adenosylmethionine transport: a potential drug target. Am J Respir Cell Mol Biol 2011, 45:1142-1146.
55. Peleg AY, Hooper DC: Hospital-acquired infections due to Gram-negative bacteria. N Engl J Med 2010, 362:1804-1813.
56. Chopra I, Schofield C, Everett M, O'Neill A, Miller K, Wilcox M, Frere JM, Dawson M, Czaplewski L, Urleb U, Courvalin P: Treatment of health-careassociated infections caused by Gram-negative bacteria: a consensus statement. Lancet Infect Dis 2008, 8:133-139.
57. Wang J, Soisson SM, Young K, Shoop W, Kodali S, Galgoci A, Painter R, Parthasarathy G, Tang YS, Cummings R, Ha S, Dorso K, Motyl M, Jayasuriya H, Ondeyka J, Herath K, Zhang C, Hernandez L, Allocco J, Basilio A, Tormo JR, Genilloud O, Vicente F, Pelaez F, Colwell L, Lee SH, Michael B, Felcetto T, Gill C, Silver LL: Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature 2006, 441:358-361.
58. Brinster S, Lamberet G, Staels B, Trieu-Cuot P, Gruss A, Poyart C: Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens. Nature 2009, 458:83-86.
59. Parsons JB, Broussard TC, Bose JL, Rosch JW, Jackson P, Subramanian C, Rock CO: Identification of a two-component fatty acid kinase responsible for host fatty acid incorporation by Staphylococcus aureus. Proc Natl Acad Sci 2014, 111:10532-10537.
60. Heath RJ, Rock CO: Fatty acid biosynthesis as a target for novel antibacterials. Curr Opin Investig Drugs 2004, 5:146-153.
61. Spalding MD, Prigge ST: Lipoic acid metabolism in microbial pathogens. Microbiol Mol Biol Rev 2010, 74:200-228.
62. Cuthbert JA, Lipsky PE: Inhibition by 6-fluoromevalonate demonstrates that mevalonate or one of the mevalonate phosphates is necessary for lymphocyte proliferation. J Biol Chem 1990, 265:18568-18575.
63. Wilding EI, Brown JR, Bryant AP, Chalker AF, Holmes DJ, Ingraham KA, Iordanescu S, So CY, Rosenberg M, Gwynn MN: Identification, Evolution, and Essentiality of the Mevalonate Pathway for Isopentenyl Diphosphate Biosynthesis in Gram-Positive Cocci. J Bacteriol 2000, 182:4319-4327.